San Jose, CA, United States of America

Gerrit Klaerner

This inventor holds 50 USPTO granted patents and 18 published patent applications, plus 10 CIPO patents and 16 EPO patents, primarily in Ion Binding Polymers. Top assignees: Relypsa, Inc., Tricida, Inc., Symyx Technologies, Inc.. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gerrit Klaerner. Retrieved from https://idiyas.com/inventor/gerrit-klaerner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 50 

% Patents Active = 74.0

 

 

Average Co-Inventor Count = 5.4

ph-index = 13

Forward Citations = 489(Granted Patents)


Location History:

  • Campbell, CA (US) (2002 - 2007)
  • San Jose, CA (US) (1999 - 2013)
  • San Francisco, CA (US) (2015)
  • Hillborough, CA (US) (2018)
  • Los Gatos, CA (US) (2009 - 2021)
  • Hillsborough, CA (US) (2018 - 2024)

Company Filing History:


Years Active: 1999-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Acid-Base Disorders
Proton-Binding Polymers
Potassium-Binding Agents
Ion Binding Compositions
Pharmaceutical Compositions
Crosslinked Polymers
Controlled-Architecture Polymers
Polymer Brushes
Gastrointestinal Tract
Hypertension Treatment
Hyperkalemia
Ion Imbalances
50 patents (USPTO):Explore Patents

Title: Gerrit Klaerner: Innovator in Pharmaceutical Compositions

Introduction

Gerrit Klaerner, based in San Jose, CA, has made significant contributions to the field of pharmaceuticals with a remarkable portfolio of 49 patents. His work primarily focuses on compositions and methods for treating acid-base disorders, which are crucial for improving the physiological conditions of patients.

Latest Patents

Among his latest innovations are two notable patents titled "Compositions for and methods of treating acid-base disorders." These patents describe pharmaceutical compositions that include non-absorbable components aimed at treating various metabolic conditions. One application is particularly geared towards normalizing serum bicarbonate concentrations and blood pH, which is vital for patients suffering from conditions related to acid-base imbalances.

Career Highlights

Gerrit has been instrumental in the success of notable companies such as Relypsa, Inc. and Tricida, Inc., where he applied his knowledge in developing groundbreaking pharmaceutical solutions. His patents and research have played a fundamental role in advancing treatment methodologies in this critical area of medicine.

Collaborations

Throughout his career, Gerrit has collaborated with esteemed professionals such as Dominique Charmot and Jerry M Buysse. These partnerships have fostered an environment of innovation, leading to the development of impactful therapeutic solutions.

Conclusion

Gerrit Klaerner's work exemplifies dedication to advancing medical treatments through innovation. His extensive patent portfolio not only highlights his inventiveness but also serves as a testament to the impact that dedicated professionals can have in the pharmaceutical industry. As research and development in the field continue to evolve, Klaerner's contributions will undoubtedly play a pivotal role in shaping future therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…